期刊文献+

HPIP在子宫内膜癌中的表达及其临床意义 被引量:3

The Expression of HPIP in Endometrial Carcinoma and Clinical Significance
下载PDF
导出
摘要 目的检测HPIP蛋白在子宫内膜癌中的表达水平及探讨其临床意义。方法应用免疫组化技术,检测HPIP在低分化子宫内膜癌(20例)、中分化子宫内膜癌(30例)、高分化子宫内膜癌(30例)以及正常内膜组织(10例)中的表达,分析其表达水平与癌细胞分级、浸润深度的相关性。结果与正常的子宫内膜及子宫内膜良性病变相比,HPIP在子宫内膜癌中呈过度表达。①HPIP的表达与组织学分级、FIGO分期、淋巴结转移有关。②HPIP蛋白在正常组织中的表达显著低于在EC中的表达,研究表明HPIP蛋白表达可能与EC的增殖、侵袭有着密切的关系。③HPIP蛋白是有可能是一个非常有价值的生物学标志物,用于预测EC患者预后,并作为治疗癌症的一个潜在靶点。结论 HPIP蛋白的高表达促进子宫内膜癌的进展,可以作为预测子宫内膜癌的新指标。 Objective To detect the expression of HPIP protein in endometrial cancer and to explore its clinical significance.Methods Immunohistochemical technique was used to detect the expression of HPIP in low differentiated endometrial cancer(20 cases),moderately differentiated endometrial cancer(30 cases),highly differentiated endometrial cancer(30 cases)and normal endometrial tissue(10 cases).Results Compared with normal endometrium and benign endometrial lesions,HPIP was overexpressed in endometrial cancer.The expression of HPIP is related to histological grade,FIGO stage and lymph node metastasis.The expression of HPIP protein in normal tissues is significantly lower than that in EC.Studies have shown that the expression of HPIP protein may be closely related to the proliferation and invasion of EC.HPIP protein may be a very valuable biomarker for predicting the prognosis of EC patients and as a potential target for cancer treatment.Conclusion High expression of HPIP protein promotes the progression of endometrial cancer and can be used as a new predictor of endometrial cancer.
作者 王海璐 田淞宇 陈秀玮 王榆平 侯思宇 WANG Hailu;TIAN Songyu;CHEN Xiuwei(Tumor Hospital of Harbin Medical University,Harbin,150081)
出处 《实用癌症杂志》 2019年第2期183-186,共4页 The Practical Journal of Cancer
基金 黑龙江省科技创新人才(编号:2015RAXYJ054) 国家自然科学基金(编号:8177080864)
关键词 子宫内膜样腺癌 免疫组化 预测 Endometrial cancer Immunohistochenistry prognosis
  • 相关文献

参考文献2

二级参考文献14

  • 1Cusido M, Fargas F, Rodrlguez I, et al. Role of lymphade- nectomy in endometrioid endometrial cancer [ J ]. Eur J Gynaecol Onco1,2011,32 ( 1 ) :49.
  • 2Horvaith K,Pete I,Vereczkey I, et al. Evaluation of the ac- curacy of preoperative MRI in measuring myometrial infil- tration in endometrial carcinoma [ J ]. Pathol Oncol Res, 2014,20(2) :327.
  • 3Dogan D, Inan N, Sarisoy HT, et al. Preoperative evaluation of myometrial invasion in endometrial carcinoma: diagnos- tic performance of 3 T MR1[ J ]. Abdom Imaging, 2013,38 (2) :388.
  • 4Ueda SM, Kapp DS, Cheung MK, et al. Trends in demo- graphic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the in- creasing number of deaths [ J ]. Am J Obstet Gynecol, 2008,198(2) :218. el.
  • 5Chan JK, Sherman AE, Kapp DS, et al. Influence of gyneco- logic oncologists on the survival of patients with endometri- al cancer[J]. J Clin 0ncol,2011,29(7) :832.
  • 6Milam MR, Java J, Walker JL, et al. Nodal metastasis risk in endometrioid endometrial cancer [ J]. Obstet Gynecol, 2012,119(2) :286.
  • 7Havrilesky LJ,Cragun JM, Calingaert B, et al. Resection of lymph node metastases influences survival in stage m C en- dometrial cancer[ J ]. Gynecol Onco1,2005,99 ( 3 ) :689.
  • 8Todo Y, Kato I-I,Kaneuchi M, et al. Survival effect of para- aortic lymphadenectomy in endometrial cancer (SEPAL study) : a retrospective cohort analysis [ J ]. Lancet, 2010, 375(9721) :1165.
  • 9ASTEC study group, Kitchener H, Swart AM, et al. Efficacy of systematic pelvic lymphadenectomy in endometrial canc- er(MRC ASTEC trial) :a randomised study[J]. Lancet, 2009,373 (9658) : 125.
  • 10Benedetti Panici P, Basile S, Maneschi F, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early- stage endometrial carcinoma : randomized clinical trial[ J ]. J Natl Cancer Inst,2008,100 ( 3 ) : 1707.

共引文献17

同被引文献16

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部